|
|
||||||||
The Journal of Immunology, Vol 153, Issue 6 2769-2777, Copyright © 1994 by American Association of Immunologists
ARTICLES |
N Haneji, H Hamano, K Yanagi and Y Hayashi
Department of Pathology, Tokushima University School of Dentistry, Japan.
In this study, we report an established and characterized animal model for primary Sjogren's syndrome in NFS/sld mutant mice bearing an autosomal recessive gene with sublingual gland differentiation arrest. Significant inflammatory changes develop spontaneously in both the salivary and lacrimal glands of NFS/sld mutant mice thymectomized 3 days after birth without any immunization, whereas no significant inflammatory lesions were found in other organs or in nonthymectomized mice. This pathology resembles primary Sjogren's syndrome in humans, which involves the parotid, submandibular salivary, and lacrimal glands. A significantly higher incidence of autoimmune lesions was found in female mice, and the anti-salivary duct autoantibodies were detected in sera from mice with autoimmune lesions but not in control mice. The inflammatory infiltration into the salivary and lacrimal glands consisted mainly of CD3+ and CD4+ T cells, and a lesser proportion of CD8+ T cells and B220+ B cells during the course of disease. When the repertoire of TCR V beta genes transcribed and expressed within the inflammatory infiltrates was analyzed in mice with autoimmune lesions, a considerable preferential use of TCR V beta gene (V beta 8 predominant) was detected in these lesions from the onset of disease. Thus, we can propose a newly established animal model for primary Sjogren's syndrome developing in this mutant strain of mice. Moreover, the predominant patterns of TCR transcript expression in an animal model may be somewhat restricted, suggesting that TCR-based immunotherapy of Sjogren's syndrome is possible.
This article has been cited by other articles:
![]() |
J. S. Oak, J. A. Deane, M. G. Kharas, J. Luo, T. E. Lane, L. C. Cantley, and D. A. Fruman Sjogren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase PNAS, November 7, 2006; 103(45): 16882 - 16887. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Scofield, S. Asfa, D. Obeso, R. Jonsson, and B. T. Kurien Immunization with Short Peptides from the 60-kDa Ro Antigen Recapitulates the Serological and Pathological Findings as well as the Salivary Gland Dysfunction of Sjogren's Syndrome J. Immunol., December 15, 2005; 175(12): 8409 - 8414. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kuroda, T. Mitani, N. Takeda, N. Ishimaru, R. Arakaki, Y. Hayashi, Y. Bando, K. Izumi, T. Takahashi, T. Nomura, et al. Development of Autoimmunity against Transcriptionally Unrepressed Target Antigen in the Thymus of Aire-Deficient Mice J. Immunol., February 15, 2005; 174(4): 1862 - 1870. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takada, M. Takiguchi, A. Konno, and M. Inaba Autoimmunity against a Tissue Kallikrein in IQI/Jic Mice: A MODEL FOR SJOGREN'S SYNDROME J. Biol. Chem., February 4, 2005; 280(5): 3982 - 3988. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takada, M. Takiguchi, A. Konno, and M. Inaba Spontaneous development of multiple glandular and extraglandular lesions in aged IQI/Jic mice: a model for primary Sjogren's syndrome Rheumatology, July 1, 2004; 43(7): 858 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
M R Kok, B J Baum, P P Tak, and S R Pillemer Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjogren's syndrome Ann Rheum Dis, November 1, 2003; 62(11): 1038 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Roper, R. D. McAllister, J. E. Biggins, S. D. Michael, S. H. Min, K. S. K. Tung, S. B. Call, J. Gao, and C. Teuscher Aod1 Controlling Day 3 Thymectomy-Induced Autoimmune Ovarian Dysgenesis in Mice Encompasses Two Linked Quantitative Trait Loci with Opposing Allelic Effects on Disease Susceptibility J. Immunol., June 15, 2003; 170(12): 5886 - 5891. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Saegusa, N. Ishimaru, K. Yanagi, K. Mishima, R. Arakaki, T. Suda, I. Saito, and Y. Hayashi Prevention and Induction of Autoimmune Exocrinopathy Is Dependent on Pathogenic Autoantigen Cleavage in Murine Sjogren's Syndrome J. Immunol., July 15, 2002; 169(2): 1050 - 1057. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cha, A.B. Peck, and M.G. Humphreys-Beher PROGRESS IN UNDERSTANDING AUTOIMMUNE EXOCRINOPATHY USING THE NON-OBESE DIABETIC MOUSE: AN UPDATE Crit. Rev. Oral. Biol. Med., January 1, 2002; 13(1): 5 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ishimaru, K. Yanagi, K. Ogawa, T. Suda, I. Saito, and Y. Hayashi Possible Role of Organ-Specific Autoantigen for Fas Ligand-Mediated Activation-Induced Cell Death in Murine Sjogren's Syndrome J. Immunol., November 15, 2001; 167(10): 6031 - 6037. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zoukhri and C. L. Kublin Impaired Neurotransmitter Release from Lacrimal and Salivary Gland Nerves of a Murine Model of Sjogren's Syndrome Invest. Ophthalmol. Vis. Sci., April 1, 2001; 42(5): 925 - 932. [Abstract] [Full Text] |
||||
![]() |
K. Tsubota, H. Fujita, K. Tadano, T. Takeuchi, T. Murakami, I. Saito, and Y. Hayashi Improvement of Lacrimal Function by Topical Application of CyA in Murine Models of Sjogren's Syndrome Invest. Ophthalmol. Vis. Sci., January 1, 2001; 42(1): 101 - 110. [Abstract] [Full Text] |
||||
![]() |
K. Saegusa, N. Ishimaru, K. Yanagi, N. Haneji, M. Nishino, M. Azuma, I. Saito, and Y. Hayashi Autoantigen-Specific CD4+CD28low T Cell Subset Prevents Autoimmune Exocrinopathy in Murine Sjogren's Syndrome J. Immunol., August 15, 2000; 165(4): 2251 - 2257. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Hirai, N. Ishida, K. Watanabe, and S. Mita Leakage of Aquaporin 5 in the Tear of Dacryoadenitis Mice Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2432 - 2437. [Abstract] [Full Text] |
||||
![]() |
N. Ishimaru, T. Yoneda, K. Saegusa, K. Yanagi, N. Haneji, K. Moriyama, I. Saito, and Y. Hayashi Severe Destructive Autoimmune Lesions with Aging in Murine Sjogren's Syndrome through Fas-Mediated Apoptosis Am. J. Pathol., May 1, 2000; 156(5): 1557 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ishimaru, K. Saegusa, K. Yanagi, N. Haneji, I. Saito, and Y. Hayashi Estrogen Deficiency Accelerates Autoimmune Exocrinopathy in Murine Sjogren's Syndrome through Fas-Mediated Apoptosis Am. J. Pathol., July 1, 1999; 155(1): 173 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Saito, K. Haruta, M. Shimuta, H. Inoue, H. Sakurai, K. Yamada, N. Ishimaru, H. Higashiyama, T. Sumida, H. Ishida, et al. Fas Ligand-Mediated Exocrinopathy Resembling Sjogren's Syndrome in Mice Transgenic for IL-10 J. Immunol., March 1, 1999; 162(5): 2488 - 2494. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Haneji, T. Nakamura, K. Takio, K. Yanagi, H. Higashiyama, I. Saito, S. Noji, H. Sugino, and Y. Hayashi Identification of -Fodrin as a Candidate Autoantigen in Primary Sjögren's SyndromeScience, April 25, 1997; 276(5312): 604 - 607. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |